Results 21 to 30 of about 51,936 (174)
Sexually Transmitted Diseases: from HPV to HTLV - clinical profile and associated factors [PDF]
Anais Brasileiros de Dermatologia, 2015 : The Brazilian Ministry of Health recommends the performance of serological tests in patients with clinical signs of Sexually Transmitted Diseases. However, data are lacking to affirm the necessity of testing these patients for human T-lymphotropic ...
Fabíola Suris da Silveira +1 more
doaj +2 more sources
Revista do Instituto de Medicina Tropical de São Paulo, 2016 Publications are often used as a measure of research work success. Human T-lymphotropic virus (HTLV) type 1 and 2 are human retroviruses, which were discovered in the early 1980s, and it is estimated that 15-20 million people are infected worldwide. This
Gregorio GONZÁLEZ-ALCAIDE +4 more
doaj +1 more source
GUILLAIN-BARRÉ syndrome and hemolytic anemia associated with HTLV-1 infection
Revista de la Facultad de Medicina Humana, 2018 Male patient, 54 years old, with a history of Guillain-Barré syndrome, treated with Gabapentin. Four months before admission presents autoimmune hemolytic anemia, treated with prednisone.
Rául Vallejos Núñez +4 more
doaj +1 more source
Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis
Viruses, 2010 Human T lymphotropic viruses (HTLVs) are complex deltaretroviruses that do not contain a proto-oncogene in their genome, yet are capable of transforming primary T lymphocytes both in vitro and in vivo.
Patrick L. Green, Priya Kannian
doaj +1 more source
Human T Lymphotropic Virus Type 1 protein Tax reduces histone levels
Retrovirology, 2008 Background Human T-Lymphotropic Virus Type-1 (HTLV-1) is an oncogenic retrovirus that causes adult T-cell leukemia/lymphoma (ATLL). The virally encoded Tax protein is thought to be necessary and sufficient for T-cell leukemogenesis.
Laybourn Paul J, Bogenberger James M
doaj +1 more source
COVID‐19 in a human T‐cell lymphotropic virus type‐1 carrier
Clinical Case Reports, 2022 This is the first report of COVID‐19 in a human T‐cell lymphotropic virus type‐1 (HTLV‐1) carrier. HTLV‐1 infection can cause immune dysfunction even in asymptomatic carriers.
Takatoshi Enomoto +17 more
doaj +1 more source
, 2007 Background The Deltaretrovirus genus comprises viruses that infect humans (HTLV), various simian species (STLV) and cattle (BLV). HTLV-I is the main causative agent in adult T-cell leukemia in endemic areas and some of the simian T-cell lymphotropic ...
Hummel, Michael +9 more
core +1 more source
Biomédica: revista del Instituto Nacional de Salud, 2018 Introduction: The human-T cell lymphotropic virus is a retrovirus with various types known so far. HTLV-I and HTLV-II are of clinically importance as they cause different diseases such as adult T-cell leukemia/lymphoma, tropical spastic paraparesis, and ...
Manuela Muñoz +4 more
doaj +1 more source
An Overview of Human T-Lymphotropic Virus Type 1 Lung Injury
Frontiers in Immunology, 2022 Previous studies have demonstrated the development of pulmonary impairment in individuals infected with human T-lymphotropic virus type 1 (HTLV-1). Complications, such as alveolitis and bronchiectasis, were found in individuals who developed tropical ...
Ápio Ricardo Nazareth Dias +5 more
doaj +1 more source
Human Pegivirus Encephalitis With Brain Detection and Response to Sofosbuvir Ledipasvir
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Human pegivirus (HPgV‐1) has been associated with severe encephalomyelitis in immunocompromised patients. Its neurological spectrum remains poorly defined. We report a slowly progressive encephalitis in a person living with well‐controlled HIV, characterized by white matter abnormalities and inflammatory cerebrospinal fluid (CSF). HPgV RNA was
Antoine Moulignier +3 more
wiley +1 more source